Logo image of SINT

SINTX TECHNOLOGIES INC (SINT) Stock Fundamental Analysis

NASDAQ:SINT - Nasdaq - US8293927039 - Common Stock - Currency: USD

1.75  +0.02 (+1.16%)

After market: 1.81 +0.06 (+3.43%)

Fundamental Rating

3

Overall SINT gets a fundamental rating of 3 out of 10. We evaluated SINT against 190 industry peers in the Health Care Equipment & Supplies industry. SINT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, SINT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SINT had negative earnings in the past year.
SINT had a negative operating cash flow in the past year.
In the past 5 years SINT always reported negative net income.
SINT had a negative operating cash flow in each of the past 5 years.
SINT Yearly Net Income VS EBIT VS OCF VS FCFSINT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

SINT has a worse Return On Assets (-117.11%) than 84.74% of its industry peers.
Looking at the Return On Equity, with a value of -283.10%, SINT is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
ROA -117.11%
ROE -283.1%
ROIC N/A
ROA(3y)-91.86%
ROA(5y)-74.54%
ROE(3y)-222.21%
ROE(5y)-157.01%
ROIC(3y)N/A
ROIC(5y)N/A
SINT Yearly ROA, ROE, ROICSINT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

SINT has a better Gross Margin (71.91%) than 81.58% of its industry peers.
SINT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SINT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.53%
GM growth 5Y29.13%
SINT Yearly Profit, Operating, Gross MarginsSINT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

5

2. Health

2.1 Basic Checks

SINT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SINT has been increased compared to 1 year ago.
Compared to 5 years ago, SINT has more shares outstanding
The debt/assets ratio for SINT is higher compared to a year ago.
SINT Yearly Shares OutstandingSINT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
SINT Yearly Total Debt VS Total AssetsSINT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

SINT has an Altman-Z score of -43.93. This is a bad value and indicates that SINT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SINT (-43.93) is worse than 91.05% of its industry peers.
There is no outstanding debt for SINT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -43.93
ROIC/WACCN/A
WACC9.42%
SINT Yearly LT Debt VS Equity VS FCFSINT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

SINT has a Current Ratio of 2.41. This indicates that SINT is financially healthy and has no problem in meeting its short term obligations.
SINT has a Current ratio of 2.41. This is comparable to the rest of the industry: SINT outperforms 45.79% of its industry peers.
SINT has a Quick Ratio of 2.15. This indicates that SINT is financially healthy and has no problem in meeting its short term obligations.
SINT has a Quick ratio of 2.15. This is comparable to the rest of the industry: SINT outperforms 52.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 2.15
SINT Yearly Current Assets VS Current LiabilitesSINT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 97.75% over the past year.
The Revenue has grown by 9.90% in the past year. This is quite good.
SINT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.18% yearly.
EPS 1Y (TTM)97.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.54%
Revenue 1Y (TTM)9.9%
Revenue growth 3Y68.26%
Revenue growth 5Y33.18%
Sales Q2Q%-39.91%

3.2 Future

The Earnings Per Share is expected to grow by 37.47% on average over the next years. This is a very strong growth
Based on estimates for the next years, SINT will show a very negative growth in Revenue. The Revenue will decrease by -16.49% on average per year.
EPS Next Y83.71%
EPS Next 2Y37.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-26.24%
Revenue Next 2Y-16.49%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SINT Yearly Revenue VS EstimatesSINT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
SINT Yearly EPS VS EstimatesSINT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 -50M -100M -150M -200M -250M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SINT. In the last year negative earnings were reported.
Also next year SINT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SINT Price Earnings VS Forward Price EarningsSINT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SINT Per share dataSINT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

A more expensive valuation may be justified as SINT's earnings are expected to grow with 37.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SINT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SINTX TECHNOLOGIES INC

NASDAQ:SINT (4/17/2025, 8:00:02 PM)

After market: 1.81 +0.06 (+3.43%)

1.75

+0.02 (+1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-19 2025-03-19/bmo
Earnings (Next)05-12 2025-05-12
Inst Owners3.41%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change0%
Market Cap4.41M
Analysts43.33
Price Target71.4 (3980%)
Short Float %4.8%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.29%
Min EPS beat(2)38.59%
Max EPS beat(2)75.98%
EPS beat(4)4
Avg EPS beat(4)61.05%
Min EPS beat(4)29.97%
Max EPS beat(4)99.64%
EPS beat(8)5
Avg EPS beat(8)32.28%
EPS beat(12)7
Avg EPS beat(12)-19.73%
EPS beat(16)10
Avg EPS beat(16)-12.73%
Revenue beat(2)1
Avg Revenue beat(2)-6.09%
Min Revenue beat(2)-24.09%
Max Revenue beat(2)11.9%
Revenue beat(4)2
Avg Revenue beat(4)-1.77%
Min Revenue beat(4)-24.09%
Max Revenue beat(4)20.48%
Revenue beat(8)4
Avg Revenue beat(8)-0.7%
Revenue beat(12)7
Avg Revenue beat(12)10.65%
Revenue beat(16)8
Avg Revenue beat(16)-1.1%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)45.21%
EPS NQ rev (3m)74.68%
EPS NY rev (1m)36.43%
EPS NY rev (3m)78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-29.03%
Revenue NY rev (1m)-2.8%
Revenue NY rev (3m)-34.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.53
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)-16.28
EYN/A
EPS(NY)-2.65
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)-3.43
OCFYN/A
SpS1.15
BVpS1.55
TBVpS1.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -117.11%
ROE -283.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.91%
FCFM N/A
ROA(3y)-91.86%
ROA(5y)-74.54%
ROE(3y)-222.21%
ROE(5y)-157.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y40.53%
GM growth 5Y29.13%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.46%
Cap/Sales 23.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 2.15
Altman-Z -43.93
F-Score5
WACC9.42%
ROIC/WACCN/A
Cap/Depr(3y)184.27%
Cap/Depr(5y)590.89%
Cap/Sales(3y)44.69%
Cap/Sales(5y)162.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.54%
EPS Next Y83.71%
EPS Next 2Y37.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.9%
Revenue growth 3Y68.26%
Revenue growth 5Y33.18%
Sales Q2Q%-39.91%
Revenue Next Year-26.24%
Revenue Next 2Y-16.49%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.77%
OCF growth 3YN/A
OCF growth 5YN/A